NasdaqCM - Delayed Quote USD

Lexaria Bioscience Corp. (LEXX)

2.2000 -0.0400 (-1.79%)
At close: April 24 at 4:00 PM EDT
All numbers in thousands
Download
Breakdown
8/31/2023
8/31/2022
8/31/2021
8/31/2020
Total Assets
3,083.9860
7,833.9270
13,266.8170
2,828.2380
Total Liabilities Net Minority Interest
403.9080
201.4370
203.2650
345.9800
Total Equity Gross Minority Interest
2,680.0780
7,632.4900
13,063.5520
2,482.2580
Total Capitalization
3,044.1180
7,948.9040
13,265.6370
2,555.8710
Common Stock Equity
3,044.1180
7,948.9040
13,265.6370
2,525.2010
Capital Lease Obligations
163.9670
49.9880
89.3930
125.4310
Net Tangible Assets
2,581.4930
7,460.4420
12,901.0140
2,233.2010
Working Capital
1,932.0370
6,783.4800
12,289.6640
1,700.0440
Invested Capital
3,044.1180
7,948.9040
13,273.5630
2,555.8710
Tangible Book Value
2,581.4930
7,460.4420
12,901.0140
2,233.2010
Total Debt
163.9670
49.9880
97.3190
156.1010
Share Issued
8,091.6500
5,950.9980
5,726.6990
3,001.4750
Ordinary Shares Number
8,091.6500
5,950.9980
5,726.6990
3,001.4750
8/31/2020 - 1/12/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers